High-Sensitive c-Reactive Protein Levels in Euthymic Bipolar Patients: Case-Control Study.
Ghada HamdiHanen Ben AmmarEmira KhelifaArij Ben ChaabenSabria KhouadjaFayza AyariOns MihoubRyad TamouzaFethi GuémiraZouhaier ElhechmiPublished in: The Psychiatric quarterly (2020)
Bipolar disorder is a chronic, disabling disease that is characterized by the recurrence of thymic episodes. The role of the immune-inflammatory system in the etiopathogenesis of this affection arouses the interest of research. The aim of this work was to determine the plasma levels of the high sensitivity C reactive protein (hs-CRP) in patients with bipolar disorder in remission phase by comparing them to a control group.A case-control cross-sectional study was conducted from 56 subjects with bipolar disorder in clinical remission, and 56 volunteers and healthy control subjects.Mean plasma hs-CRP was significantly higher in patients with bipolar disorder than control subjects. In bipolar patients, a hs-CRP elevation was significantly associated with the disease severity item mean score.Through this study, bipolar disorder appears to be associated with a state of chronic inflammation. This should lead to randomized controlled trials evaluating the value of anti-inflammatory drugs in the management of bipolar disorder.
Keyphrases
- bipolar disorder
- major depressive disorder
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- randomized controlled trial
- oxidative stress
- prognostic factors
- peritoneal dialysis
- clinical trial
- rheumatoid arthritis
- patient reported outcomes
- systemic lupus erythematosus
- patient reported
- drug induced
- free survival